About Deoxyribonuclease-2-alpha
Deoxyribonuclease-2-alpha (DNASE2) is a protein
from Homo sapiens identified by UniProt accession
O00115, 360 residues long.
MolForge cross-references it against 0 known binders and
185 disease associations.
Target properties
| Protein name | Deoxyribonuclease-2-alpha |
| UniProt accession | O00115 |
| Gene | DNASE2 |
| Organism | Homo sapiens |
| Length | 360 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (185)
Diseases linked to this target (Open Targets).
- autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency · score 0.69
- mean corpuscular hemoglobin · score 0.19
- reticulocyte count · score 0.16
- mean corpuscular volume · score 0.14
- mean corpuscular hemoglobin concentration · score 0.13
- erythrocyte count · score 0.13
- lymphocyte percentage of leukocytes · score 0.12
- body mass index · score 0.12
- neutrophil percentage of leukocytes · score 0.12
- systemic lupus erythematosus · score 0.11
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O00115-F1 | alphafold | PREDICTED | 91.05 | — |
Amino-acid sequence (360 residues)
MIPLLLAALL CVPAGALTCY GDSGQPVDWF VVYKLPALRG SGEAAQRGLQ YKYLDESSGG WRDGRALINS PEGAVGRSLQ PLYRSNTSQL AFLLYNDQPP QPSKAQDSSM RGHTKGVLLL DHDGGFWLVH SVPNFPPPAS SAAYSWPHSA CTYGQTLLCV SFPFAQFSKM GKQLTYTYPW VYNYQLEGIF AQEFPDLENV VKGHHVSQEP WNSSITLTSQ AGAVFQSFAK FSKFGDDLYS GWLAAALGTN LQVQFWHKTV GILPSNCSDI WQVLNVNQIA FPGPAGPSFN STEDHSKWCV SPKGPWTCVG DMNRNQGEEQ RGGGTLCAQL PALWKAFQPL VKNYQPCNGM ARKPSRAYKI
Explore Deoxyribonuclease-2-alpha with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets